Interleukin-1 formulation

Details Interleukin-1 formulation Interleukin-1 formulation

A - Human Necessities

61

K

A61K 38/20 (2006.01) A61K 9/19 (2006.01) A61K 47/18 (2006.01) A61K 47/26 (2006.01)

Patent

CA 2014103

26650-FF ABSTRACT OF THE DISCLOSURE A lyophilized dosage form for human recombinant interleukin-1 (IL-1) is disclosed. Specifically described is a lyophilized dosage form of interleukin-1.beta. which retains its intrinsic potency for a minimum of one year when stored at ambient temperature.

Affiliated with

Also associated with

Rating

Interleukin-1 formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Interleukin-1 formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Interleukin-1 formulation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1627632